Evidence map›Paper›PMID 28679298›Full record

ArticleLeukemia & lymphoma2018

Prevalence of cutaneous viral infections in incident cutaneous squamous cell carcinoma detected among chronic lymphocytic leukemia and hematopoietic stem cell transplant patients.

Shalaka S Hampras, Frederick L Locke, Julio C Chavez, Nishit S Patel, Anna R Giuliano, Kyle Miller, Tarik Gheit, Massimo Tommasino, Dana E Rollison

Registry-linked trialAbstract read
In one paragraph

Article in Leukemia & lymphoma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04844528 (Randomized Phase 2 Studying the Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04844528 phase2recruitingnot on this mapstarted 2022, after this paper: background citation

Randomized Phase 2 Studying the Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)

TypeinterventionalSponsorUniversity of UtahRan2022 to 2028Enrolled86ConditionsChronic Lymphocytic Leukemia, Non-melanoma Skin Cancer (NMSC)ArmsNicotinamide, Placebo
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Shalaka S Hamprasa Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.ORCID 0000-0001-8876-2082
Frederick L Lockeb Department of Blood and Marrow Transplant and Cellular Immunotherapy , Moffitt Cancer Center , Tampa , FL , USA.
Julio C Chavezc Department of Malignant Hematology , Moffitt Cancer Center , Tampa , FL , USA.
Nishit S Pateld Department of Dermatology and Cutaneous Surgery, Morsani College of Medicine , University of South Florida , Tampa , FL , USA.
Anna R Giulianoa Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.
Kyle Millerf College of Agriculture and Life Sciences, University of Florida, Gainesville , Tampa , FL , USA.
Tarik Gheitg Infections and Cancer Biology Group , International Agency for Research on Cancer-World Health Organization , Lyon , France.
Massimo Tommasinog Infections and Cancer Biology Group , International Agency for Research on Cancer-World Health Organization , Lyon , France.
Dana E Rollisona Department of Cancer Epidemiology , Moffitt Cancer Center , Tampa , FL , USA.
Moffitt Cancer Center · USCentre international de recherche sur le cancer · FRUniversity of Florida · USUniversity of South Florida · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Breaking immune tolerance to Survivin in Multiple MyelomaK23CA201594 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI LOCKE, FREDERICK · 2015 to 2019
$821k
NCI NIH HHS K23 CA201594NCI NIH HHS P30 CA076292World Health Organization 001
6 · The paper itself

Abstract

The role of cutaneous viral infections in the development of non-melanoma skin cancer (NMSC), including cutaneous squamous cell carcinoma (SCC), among chronic lymphocytic leukemia (CLL) and blood and marrow transplant (BMT) patients is not established. CLL (n = 977) and BMT (n = 3587) patients treated at the Moffitt Cancer Center were included in a retrospective cohort study. Human papillomavirus (HPV) and human polyomavirus (HPyV) DNA were examined in a subset of incident SCC tumors. Five-year cumulative incidence of NMSC was 1.42% in both BMT (n = 31 NMSCs) and CLL (n = 18 NMSCs) cohorts. Of the nine SCC tumors examined from each cohort, 22.2% and 33.3% were positive for viral DNA in the transplant (HPV 65, MCV) and CLL (HPV 38, HPV 15, HPyV6) cohort, respectively. Enhanced skin cancer screening of BMT/CLL patients should be conducted to better capture incident NMSCs and examine the role of viral infections in these tumors.

Indexed as

AdultAgedCarcinoma, Squamous CellDNA, ViralFemaleHematopoietic Stem Cell TransplantationHumansImmunocompromised HostIncidenceLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedMyeloablative AgonistsPapillomaviridaePapillomavirus InfectionsPolyomavirusDNA, ViralMyeloablative Agonistsbone marrow transplantChronic lymphocytic leukemiaHPVpolyomavirussquamous cell carcinoma

Identifiers

PMID28679298
PMCPMC6150603
OpenAlexW2729345638

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.